Pseudoephedrine Hydrochloride
- Product NDC
- 50090-4546
- 11-digit product format
- 500904546
- Labeler code
- 50090
- Product ID
- 50090-4546_0510b7be-7889-42a1-8992-f47faefd2bd3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Pseudoephedrine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2019-08-26
- Substance
- PSEUDOEPHEDRINE HYDROCHLORIDE
- Active strength
- 60 mg/1
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 50090-4546 | 50090-4546-0 | D | Discontinued by firm | 2026-11-16 | |
| excluded package | package | 50090-4546 | 50090-4546-3 | D | Discontinued by firm | 2026-11-16 | |
| excluded package | package | 50090-4546 | 50090-4546-4 | D | Discontinued by firm | 2026-11-16 | |
| excluded package | package | 50090-4546 | 50090-4546-5 | D | Discontinued by firm | 2026-11-16 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 50090-4546-3 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 50090-4546-0 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 50090-4546-4 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 50090-4546-5 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 50090-4546-3 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 50090-4546-0 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 50090-4546-4 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 50090-4546-5 | f5e01cc5f278… | a2eaf40c39c3… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pseudoephedrine Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PSEUDOEPHEDRINE HYDROCHLORIDE | 60 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6V9V2RYJ8N | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1049167 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 810ce630-41be-4e15-b64a-d70f63abaf62 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ba088a92-ab5e-b2d4-e908-f5ea691b7587 | Product name | 7 | 20210201 |
| 0fdb98e2-b951-a1ce-5715-2b187ba500ef | Product name | 4 | 20170718 |
| e974e22d-8688-7d92-1e87-40c1079e170c | Product name | 3 | 20151125 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 30c51294-7ae9-8007-7de6-58222684a0be | Product name | 1 | 20140508 |
| 4f26f669-fc6c-40ef-9e26-1c7b2390ee66 | Product name | 1 | 20140508 |
| 70a83adc-6047-bbea-5a08-dfd304aa47d2 | Product name | 1 | 20140508 |
| 858ce051-9941-aafc-8c7c-44a8e0227463 | Product name | 1 | 20140508 |
| b893258d-0942-3d8a-3411-056ea0788ff5 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50090-4546-0 | 2023-02-07 | 1215-Major |
| 50090-4546-1 | 2023-02-07 | 1215-Major |
| 50090-4546-3 | 2023-02-07 | 1215-Major |
| 50090-4546-4 | 2023-02-07 | 1215-Major |
| 50090-4546-5 | 2023-02-07 | 1215-Major |
| 50090-4546-0 | 2023-01-30 | 1215-Major |
| 50090-4546-1 | 2023-01-30 | 1215-Major |
| 50090-4546-3 | 2023-01-30 | 1215-Major |
| 50090-4546-4 | 2023-01-30 | 1215-Major |
| 50090-4546-5 | 2023-01-30 | 1215-Major |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-4546-0 | Pseudoephedrine Hydrochloride | 24 in 1 BOTTLE | TABLET | 24 | 17 | |
| 50090-4546-1 | Pseudoephedrine Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 17 | |
| 50090-4546-3 | Pseudoephedrine Hydrochloride | 12 in 1 BOTTLE | TABLET | 12 | 17 | |
| 50090-4546-4 | Pseudoephedrine Hydrochloride | 20 in 1 BOTTLE | TABLET | 20 | 17 | |
| 50090-4546-5 | Pseudoephedrine Hydrochloride | 15 in 1 BOTTLE | TABLET | 15 | 17 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-4546-1 | EA - Each | 50090-4546 | 103bdf42-6855-49a0-9cff-e992b024c975 | 1 | 2022-07-06 |
| 50090-4546-3 | EA - Each | 50090-4546 | 42cccd03-ae3d-44ad-b461-dfea29a316e2 | 1 | 2021-05-05 |
| 50090-4546-4 | EA - Each | 50090-4546 | 75464fe6-9da2-4ee1-b365-1ad34e24d650 | 1 | 2022-07-06 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-4546 | PSEUDOEPHEDRINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS] | 17 | Current NDC, Legacy NDC, 5 package rows | 20250426_810ce630-41be-4e15-b64a-d70f63abaf62.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Allergy Relief | CHLORPHENIRAMINE MALEATE | Good Sense | f88e2654-8e97-4cf6-9c36-01aeb51a9102 | 2021-11-30 | Warnings | M012 |
| Cold Medicine | COLD MEDICINE | Allegiant Health | 443fbc44-2c33-4316-ad31-dcc5a5aa8f52 | 2021-11-23 | Warnings | M012 |
| Decongestant PE Non Drowsy | PHENYLEPHRINE HCL | Allegiant Health | 7a3098b4-381c-4f32-97a7-87b53fd64428 | 2021-06-16 | Warnings | M012 |
| Mucus Relief Immediate Release | GUAIFENESIN 400MG | Good Sense | e7c68746-7ec0-46cf-b4a3-174fab819b5e | 2021-05-05 | Warnings | M012 |
| Mucus Relief Immediate Release | GUAIFENESIN 400MG | TopCo Associates, LLC | 7d91c6ab-d161-42b9-b353-0aa8f59619f8 | 2021-01-21 | Warnings | M012 |
| Daytime Cold and Flu | ACETAMINOPHEN 325MG/ DEXTROMETHORPHAN HBR 10MG/ PHENYLEPHRINE HCL 5MG | Allegiant Health | bed5f9dc-45ea-4e90-86c6-86599b6f3861 | 2020-11-16 | Warnings | M012 |
| Nighttime Cold and Flu Relief | ACETAMINOPHEN | Allegiant Health | b97126d7-847d-483e-b3d1-e2b61ab1743f | 2020-11-11 | Warnings | M012 |
| Cold and Allergy | PHENYLEPHRINE HCL AND CHLORPHENIRAMINE MALEATE | Allegiant Health | 7af63769-fa56-4f1f-a2ad-5b4c108c8e4f | 2019-12-12 | Warnings | M012 |
| Mucus Relief Immediate Release | GUAIFENESIN | Allegiant Health | 221d64a2-b8c7-435a-aae4-fb58fd38108f | 2019-03-26 | Warnings | M012 |
| Sleep Tabs For Nighttime use | DIPHENHYDRAMINE HCL TABLETS | Allegiant Health | 566e40b1-e9d7-44e4-b971-eef2b7cf0a7d | 2018-12-26 | Warnings | M012 |
| Allergy | CHLORPHENIRAMINE MALEATE | Allegiant Health | 4305ad50-d2a5-4d3e-9d92-cbf26e856a16 | 2018-12-26 | Warnings | M012 |
| Sleep Aid | DIPHENHYDRAMINE HCL 25 MG | Allegiant Health | dbbc535f-515a-4d9b-b799-34e60f5230bb | 2018-12-21 | Warnings | M012 |
| Allergy | DIPHENHYDRAMINE HCL | Allegiant Health | c2823bad-540f-4662-8dcc-58e9f0d94efb | 2018-11-07 | Warnings | M012 |
| Nasal Decongestant PE Maximum Strength Non-Drowsy | PHENYLEPHRINE 10 MG | Allegiant Health | 7aef00df-816a-4ea2-a2ad-beed66dd2fe4 | 2018-11-07 | Warnings | M012 |
| DEXTROMETHORPHAN HYDROBROMIDE, Guaifenesin, and PHENYLEPHRINE HYDROCHLORIDE | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Westminster Pharmaceuticals, LLC | a58bfb14-28f9-4425-a5a5-aaff4847c979 | 2018-03-14 | Warnings | M012 |
| Chlorpheniramine maleate 4mg | CHLORPHENIRAMINE MALEATE 4MG | Athlete's Needs, Inc. | 4d974959-25fc-4707-9b72-9afbf47b76f1 | 2017-11-14 | Warnings | M012 |
| Cold Medicine | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | Selder, S.A. de C.V. | d2762d9c-e7e7-42b2-a26a-14b2aa0307cb | 2017-01-25 | Warnings | M012 |
| Allergy | CHLORPHENIRAMINE MALEATE | Marc Glassman, Inc. | 2051247f-ce64-4cf5-b449-9ca14c43ab86 | 2016-12-27 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1049167 | pseudoephedrine HCl 60 MG Oral Tablet | PSN | 810ce630-41be-4e15-b64a-d70f63abaf62 | 17 |
| 1049167 | pseudoephedrine hydrochloride 60 MG Oral Tablet | SCD | 810ce630-41be-4e15-b64a-d70f63abaf62 | 17 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50090-4546-0 | 50090454600 | 24 TABLET in 1 BOTTLE (50090-4546-0) | 24 tablet | 2019-09-20 | 0000-00-00 | No | No | Current |
| 50090-4546-1 | 50090454601 | 30 TABLET in 1 BOTTLE (50090-4546-1) | 30 tablet | 2019-09-20 | 0000-00-00 | No | No | Current |
| 50090-4546-3 | 50090454603 | 12 TABLET in 1 BOTTLE (50090-4546-3) | 12 tablet | 2019-09-27 | 0000-00-00 | No | No | Current |
| 50090-4546-4 | 50090454604 | 20 TABLET in 1 BOTTLE (50090-4546-4) | 20 tablet | 2019-09-20 | 0000-00-00 | No | No | Current |
| 50090-4546-5 | 50090454605 | 15 TABLET in 1 BOTTLE (50090-4546-5) | 15 tablet | 2019-09-20 | 0000-00-00 | No | No | Current |